Skip to main content

Table 3 Percentage of participants with drug intake by baseline BMI group

From: Impact of BMI and BMI change on future drug expenditures in adults: results from the MONICA/KORA cohort study

   Total By BMI group  
    Normal weight Overweight Moderate obesity Severe obesity p-valuea
   n = 2,946 n = 1,064 n = 1,327 n = 434 n = 121  
Percentage   67.9% 60.3% 68.6% 78.8% 90.1% <.0001
Percentage by ATC group A: Alimentary tract and metabolism 16.3% 8.6% 17.3% 25.1% 42.1% <.0001
B: Blood and blood-forming organs 13.5% 7.9% 15.7% 18.7% 21.5% 0.3732
C: Cardiovascular system 36.9% 19.1% 40.5% 60.1% 70.2% <.0001
  G: Genitourinary system and sex hormones 12.8% 16.7% 10.8% 9.2% 14.0% 0.2158
  H: Systemic hormonal preparations, excl. sex hormones + insulins 14.8% 12.9% 13.6% 19.8% 28.1% 0.0004
  M: Musculoskeletal system 16.5% 11.6% 16.3% 27.0% 24.8% <.0001
  N: Nervous system 16.4% 14.9% 16.2% 20.0% 19.0% 0.5355
  R: Respiratory system 8.2% 7.7% 8.1% 9.4% 9.1% 0.4434
  1. ap-values were adjusted for age, sex and SES.